Lung mass resident survival guide: Difference between revisions

Jump to navigation Jump to search
Line 73: Line 73:
==Complete Diagnostic Approach==
==Complete Diagnostic Approach==
A complete diagnostic approach should be carried out after a focused initial rapid evaluation is conducted and following initiation of any urgent intervention.
A complete diagnostic approach should be carried out after a focused initial rapid evaluation is conducted and following initiation of any urgent intervention.
{{familytree/start}}
{{familytree | | | | | | | | A01 | | | | | | | |A01=<div style="float: left; text-align: left; width: 30em; padding:1em;"> '''Characterize the symptoms:'''<br>
❑ Low grade fever <br>
❑ [[Cough]]<br>
❑ [[Chest pain]] <br>
❑ [[Dyspnea]]<br>
:❑ At rest<br>
:❑ Exertional<br>
❑ [[Wheezing]]<br>
❑ Hemoptysis<br>
❑ [[Anorexia]]<br>
❑ [[Cyanosis]]<br>
❑ Hoarseness<br>
❑ [[Fatigue]]<br>
❑ [[Syncope]]<br>
----
'''Obtain a detailed history:'''<br>
❑ '''Past medical history'''<br>
❑Personal history of cancer<br>
❑Family history of cancer<br>
❑Positive history of active/passive smoking<br>
:❑Number of cigarettes/year<br>
:❑Number of years/months of active smoking<br>
:❑Number of years/months of second-hand smoking<br>
:❑Number of years/months of smoking cessation<br>
❑Previous primary infection of tuberculosis<br>
❑Onset of pulmonary symptoms<br>
❑Acute (< 6 weeks)<br>
❑Chronic (> 6 weeks)<br>
❑Previous or current lung disease, such as:<br>
:❑Chronic obstructive pulmonary disease<br>
:❑Interstitial lung disease<br>
❑ '''Medication history'''<br>
:❑ Intake of the following drugs:<br>
::❑ [[Alcohol]]<br>
::❑ [[Chemotherapy]] drugs - [[anthracyclines]]<br>
{{familytree | | | | | | | | |!| | | | | | | | |
{{familytree | | | | | | | | B01 | | | |B01=  '''Examine the patient:'''<br>'''General appearance:'''<br>
❑Older age in relation to chronological age <br>
❑Lethargic <br>
❑Confused <br>
'''Vitals:'''<br>
❑Low-grade fever<br>
❑Decreased SPO2<br>
❑Tachypnea<br>
❑Tachycardia<br>
'''Weight:'''<br>
❑ Measure weight daily at the same time after the first void<br>
'''Skin'''<br>
❑ [[Cool extremities|Cool and clammy]] (suggestive of hypoperfusion)<br>
❑ [[Cyanosis]] (suggestive of severe [[hypoxemia]])<br>
❑ [[Anasarca]]<br>
'''Neck examination:'''<br>
❑ [[Jugular vein distention]] (suggestive of Pulmonary HTN) <br>
❑ Positive [[hepatojugular reflux]] <br>
''Respiratory examination'''<br>
❑ [[Wheeze]]<br>
❑ Dullness at lung bases (suggestive of [[pleural effusion]], may be present in chronic HF secondary to lymphatic compensation)<br>
❑ [[Crackles]]/[[crepitations]]/[[rales]] (suggestive of [[pleural effusion]])<br>
❑ [[Cheyne-stokes respiration]]<br>
'''Abdominal examination'''<br>
❑ [[Hepatomegaly]]<br>


==References==
==References==

Revision as of 22:50, 6 March 2018

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief:

Overview

Lung mass (also known as "Pulmonary mass") is defined as any area of pulmonary opacification that measures more than 30 mm (3 cms) in the lung. Lung mass are abnormal growths found in the lung which can be either be benign or malignant. The most common cause of a pulmonary mass is lung cancer. Other causes of lung mass include granuloma, lipoma, tuberculosis, and aspergillosis.

Classification

Lung mass may be classified on the basis of histopathology into benign lung mass and malignant lung mass. In addition, lung mass can be sub-classified according to the location, imaging features, size, and distribution.

 
 
 
 
 
 
 
Lung mass
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Location
 
 
 
Histology
 
 
 
Imaging Features
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
•Pleural
•Endobronchial
•Parenchymal
 
 
 
•Malignant mass
•Benign mass
 
 
 
•Hyperdense pulmonary mass
•Cavitating pulmonary mass

Causes

The common causes of lung mass include:[1][2][3][4][5]

FIRE: Focused Initial Rapid Evaluation

A Focused Initial Rapid Evaluation (FIRE) should be performed to identify patients of lung mass.

 
 
 
 
 
 
 
 
 
 
Identify cardinal findings that increase the pretest probability of lung mass
Dyspnea
❑ Chronic cough
Hemoptysis
Wheezing
❑ Chest pain
❑Cachexia
❑Fatigue
❑Loss of appetite
❑Dysphonia
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Advise chest x ray (CXR)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Lung opacity on Chest X ray (CXR)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Size >3 cms; classified as lung mass
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Size <3 cms; classified as pulmonary nodule
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
High resolution chest CT scan
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Check previous CXR
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Imaging features
 
 
 
 
 
 
 
 
 
 
 
 
Previous CXR normal; suggesting new growth
 
 
 
Previous CXR shows opacity but stable in size since then
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Hyperdense pulmonary mass
❑Internal/eccentric calcification
 
 
 
Cavitating pulmonary mass
❑ Gas-filled area
❑ Thick/spiculated wall (must be greater than 2-5 mm)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Follow up every 2-3 yrs
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Other diagnostic studies
❑ Sputum cytology

❑ Endobronchial ultrasound
❑ Endoscopic ultrasound
❑ Bronchoscopy
❑ Mediastinoscopy
 
 
 
 
 
 
 
 
 
 
 
 
High resolution chest CT scan
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Highly suspicious for malignancy
•Age >60yrs
•Current smoker
•Size >2cms
 
 
 
Suspicious for malignancy
•Age 40-60yrs
•Current smoker
•Size 0.8-2cms
 
 
 
 
Benign features
•Age <40yrs
•Non smoker
•Size <0.8cm
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
PET or biopsy
 
 
 
 
Serial CT scans
 
 
 
 
 
PET with biopsy
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Malignancy
 
No evidence of malignancy
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Surgical excision/Chemo depending upon histopathology
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
No growth over time
 
 
Lesion grows over time
 
 
 
 
 
 
 
 
 
 
 
 
 
Surgical excision/Chemo depending upon histopathology
 
Serial CT scans
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
No further workup
 
 
PET with or biopsy
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Surgical excision/Chemo depending upon histopathology


Complete Diagnostic Approach

A complete diagnostic approach should be carried out after a focused initial rapid evaluation is conducted and following initiation of any urgent intervention.

{{familytree | | | | | | | | A01 | | | | | | | |A01=
Characterize the symptoms:

❑ Low grade fever
Cough
Chest pain
Dyspnea

❑ At rest
❑ Exertional

Wheezing
❑ Hemoptysis
Anorexia
Cyanosis
❑ Hoarseness
Fatigue
Syncope


Obtain a detailed history:
Past medical history
❑Personal history of cancer
❑Family history of cancer
❑Positive history of active/passive smoking

❑Number of cigarettes/year
❑Number of years/months of active smoking
❑Number of years/months of second-hand smoking
❑Number of years/months of smoking cessation

❑Previous primary infection of tuberculosis
❑Onset of pulmonary symptoms
❑Acute (< 6 weeks)
❑Chronic (> 6 weeks)
❑Previous or current lung disease, such as:

❑Chronic obstructive pulmonary disease
❑Interstitial lung disease

Medication history

❑ Intake of the following drugs:
Alcohol
Chemotherapy drugs - anthracyclines

{{familytree | | | | | | | | |!| | | | | | | | | {{familytree | | | | | | | | B01 | | | |B01= Examine the patient:
General appearance:
❑Older age in relation to chronological age
❑Lethargic
❑Confused

Vitals:
❑Low-grade fever
❑Decreased SPO2
❑Tachypnea
❑Tachycardia

Weight:
❑ Measure weight daily at the same time after the first void

Skin
Cool and clammy (suggestive of hypoperfusion)
Cyanosis (suggestive of severe hypoxemia)
Anasarca

Neck examination:
Jugular vein distention (suggestive of Pulmonary HTN)
❑ Positive hepatojugular reflux

Respiratory examination'
Wheeze
❑ Dullness at lung bases (suggestive of pleural effusion, may be present in chronic HF secondary to lymphatic compensation)
Crackles/crepitations/rales (suggestive of pleural effusion)
Cheyne-stokes respiration


Abdominal examination
Hepatomegaly

References

  1. CDC (Dec 1986). "1986 Surgeon General's report: the health consequences of involuntary smoking". CDC. PMID 3097495. Retrieved 2007-08-10.
    * National Research Council (1986). Environmental tobacco smoke: measuring exposures and assessing health effects. National Academy Press. ISBN 0-309-07456-8.
    * Template:Cite paper
    * California Environmental Protection Agency (1997). "Health effects of exposure to environmental tobacco smoke". Tobacco Control. 6 (4): 346–353. PMID 9583639. Retrieved 2007-08-10.
    * CDC (Dec 2001). "State-specific prevalence of current cigarette smoking among adults, and policies and attitudes about secondhand smoke—United States, 2000". Morbidity and Mortality Weekly Report. CDC. 50 (49): 1101–1106. PMID 11794619. Retrieved 2007-08-10.
    * Alberg, AJ (Jan 2003). "Epidemiology of lung cancer". Chest. American College of Chest Physicians. 123 (S1): 21S–49S. PMID 12527563. Retrieved 2007-08-10. Unknown parameter |coauthors= ignored (help)
  2. Parent, ME (Jan 2007). "Exposure to diesel and gasoline engine emissions and the risk of lung cancer". American Journal of Epidemiology. 165 (1): 53–62. PMID 17062632. Unknown parameter |coauthors= ignored (help)
  3. Boffetta, P (Oct 1998). "Multicenter case-control study of exposure to environmental tobacco smoke and lung cancer in Europe". Journal of the National Cancer Institute. Oxford University Press. 90 (19): 1440–1450. PMID 9776409. Retrieved 2007-08-10. Unknown parameter |coauthors= ignored (help)
  4. "Report of the Scientific Committee on Tobacco and Health". Department of Health. Mar 1998. Retrieved 2007-07-09.
    * Hackshaw, AK (Jun 1998). "Lung cancer and passive smoking". Statistical Methods in Medical Research. 7 (2): 119–136. PMID 9654638.
  5. Template:Cite paper

Template:Tumors

Template:WikiDoc Sources